Zenas BioPharma, Inc.’s ZBIO share price has surged by 11.36%, which has investors questioning if this is right time to sell.

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

Tolebrutinib was found to delay disability progression in people with nonrelapsing secondary progressive MS in a Phase 3 clinical trial.

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of ...

Using advanced microscopes that capture brain cell anatomy and activity, a portion of a mouse's brain was mapped and rendered ...